Effects of Flaxseed Interventions on Circulating Inflammatory Biomarkers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Abstract

There have been various clinical studies on the effect of flaxseed-derived products on circulating inflammatory biomarkers, but the findings from these are contradictory. The aim of the present study was to clarify any association. A comprehensive literature search was conducted from inception to May 2018. From the eligible trials, 32 articles describing studies conducted on adults aged 18-70 y were selected for the meta-analysis. Meta-analyses using the random-effects model were performed to investigate the data and results showed significant effects of flaxseed intake on circulating high-sensitivity CRP (hs-CRP) [weighted mean difference (WMD)\xa0=\xa0-0.75; 95% CI: -1.19, -0.30; P\xa0<\xa00.001] and TNFα (WMD\xa0=\xa0-0.38; 95% CI: -0.75,-0.01; P\xa0=\xa00.04). However, no significant changes were found in IL6 concentration (WMD\xa0=\xa0-0.24; 95% CI: -0.70, 0.21; P\xa0=\xa00.28) and C-reactive protein (CRP) (WMD\xa0=\xa0-0.34; 95% CI:-0.89, 0.20; P\xa0=\xa00.22). Moreover, by eliminating 1 of the studies from the sensitivity analysis, changes in IL6 concentration were significant (WMD\xa0=\xa0-0.44; 95% CI: -0.81, -0.08). The changes in inflammatory biomarkers were dependent on study design (parallel or crossover), supplement type (flaxseed, flaxseed oil, or lignan), study quality (high or low), and participants age and BMI. According to this meta-analysis, flaxseed significantly reduced circulating concentrations of hs-CRP and TNFα, but did not affect IL6 and CRP. Further research is needed to examine the effect of different doses and long-term benefits of flaxseed and its derivatives on inflammatory factors.